New developments in diagnostics and treatment of adult-onset focal dystonia

LM Centen, ME Van Egmond… - Current opinion in …, 2023 - journals.lww.com
Accurate phenotyping and (sub) classification of patients with dystonia is important for
improving diagnosis, subsequent treatment effect and population-based study outcomes in …

The dystonia coalition: a multicenter network for clinical and translational studies

G Kilic-Berkmen, LJ Wright, JS Perlmutter… - Frontiers in …, 2021 - frontiersin.org
Dystonia is a movement disorder characterized by sustained or intermittent muscle
contractions causing abnormal postures, repetitive movements, or both. Research in …

Head movement dynamics in dystonia: a multi-centre retrospective study using visual perceptive deep learning

R Peach, M Friedrich, L Fronemann… - npj Digital …, 2024 - nature.com
Dystonia is a neurological movement disorder characterised by abnormal involuntary
movements and postures, particularly affecting the head and neck. However, current clinical …

Development and validation of the dystonia‐pain classification system: a multicenter study

C Listik, E Listik, F de Paiva Santos Rolim… - Movement …, 2023 - Wiley Online Library
Background Dystonia is associated with disabling nonmotor symptoms like chronic pain
(CP), which is prevalent in dystonia and significantly impacts the quality of life (QoL). There …

Cortical neuronal hyperexcitability and synaptic changes in SGCE mutation-positive myoclonus dystonia

A Sperandeo, C Tamburini, Z Noakes, DC de la Fuente… - Brain, 2023 - academic.oup.com
Myoclonus dystonia is a childhood-onset hyperkinetic movement disorder with a combined
motor and psychiatric phenotype. It represents one of the few autosomal dominant inherited …

Efficacy and safety of DaxibotulinumtoxinA for injection in cervical dystonia: ASPEN-1 phase 3 randomized controlled trial

CL Comella, J Jankovic, RA Hauser, AT Patel… - Neurology, 2024 - AAN Enterprises
Background and Objectives ASPEN-1 was a phase 3, randomized, double-blind, placebo-
controlled study to evaluate the efficacy, duration of response, and safety of 2 doses of …

improving the efficacy of botulinum toxin for cervical dystonia: A scoping review

R Erro, M Picillo, MT Pellecchia, P Barone - Toxins, 2023 - mdpi.com
Cervical dstonia (CD) is a chronic disorder with a significant detrimental impact on quality of
life, requiring long-term treatment. Intramuscular injections of botulinum neurotoxin (BoNT) …

Adult‐onset idiopathic dystonia: A national data‐linkage study to determine epidemiological, social deprivation, and mortality characteristics

GA Bailey, A Rawlings, F Torabi… - European journal of …, 2022 - Wiley Online Library
Background and purpose Accurate epidemiological information is essential for the improved
understanding of dystonia syndromes, as well as better provisioning of clinical services and …

Effects of botulinum toxin therapy on health-related quality of life evaluated by the oromandibular dystonia rating scale

K Yoshida - Toxins, 2022 - mdpi.com
Oromandibular dystonia (OMD) refers to a focal dystonia in the stomatognathic system.
Health-related quality of life (HRQoL) in isolated dystonia is associated with non-motor …

An overview of the pharmacotherapeutics for dystonia: advances over the past decade

O Abu-Hadid, J Jimenez-Shahed - Expert Opinion on …, 2022 - Taylor & Francis
Introduction Dystonia is the third most common movement disorder, impacting quality of life
and work productivity. Its pathogenesis is heterogeneous, and many pharmacotherapeutics …